MedPath

Effects of grain constituent on postprandial hyperglycemia : placebo-controlled double blind cross-over trial

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000017447
Lead Sponsor
QOL RD Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who take continuous medical treatment. 2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease. 3) Subjects with serious infection 4) Subjects with smoking habit 5) Those whose amount of drinking on the 1st is more than 500 ml in beer conversion. 6) Subjects who are doing carbohydrates restricted diet now. 7) Subjects who participate in other clinical trials. 8) Subjects who are not eligible due to physician's judgment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood samples were collected before ingestion and 0.5,1,2,3,4 and 5 hours after ingestion.Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial reriods for 5 hrs. Primary outcome is postprandial blood glucose
Secondary Outcome Measures
NameTimeMethod
Key secondary outcomes are insulin, triglyceride and glucose-dependent insulinotropic polypeptide.
© Copyright 2025. All Rights Reserved by MedPath